For instance, serum prostate-specific antigen (PSA) level for the screening of prostate cancer was also found to be elevated in patients with breast or lung tumors, leading to 70% failure of early prostate cancer detection [17], [18]. This evidence concerns the gene KLK3 and Familial prostate cancer.